Rigel Pharmaceuticals (RIGL)

07:05 AM

Cantor Fitzgerald Forecasts RIGL FY2025 Earnings - MarketBeat

07:05 AM

Jan 21, 2025

JW Pharmaceutical gains approval for immune thrombocytopenia treatment TavalisseCHOSUNBIZ - 조선비즈

Jan 21, 2025

Jan 20, 2025

Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Shares Sold by Assenagon Asset Management S.A. - MarketBeat

Jan 20, 2025

Jan 20, 2025

Long Term Trading Analysis for (RIGL) - Stock Traders Daily

Jan 20, 2025

Jan 20, 2025

KFDA approves immune thrombocytopenia treatment Tavalisse from Rigel PharmaceuticalsCHOSUNBIZ - 조선비즈

Jan 20, 2025

Jan 20, 2025

Assenagon Asset Management S.A. Sells 30,987 Shares of Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) - Defense World

Jan 20, 2025

Jan 19, 2025

Barclays PLC Grows Position in Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) - MarketBeat

Jan 19, 2025

Jan 18, 2025

Short Interest in Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Rises By 27.1% - MarketBeat

Jan 18, 2025

Jan 18, 2025

Wall Street Analysts Predict a 75.79% Upside in Rigel (RIGL): Here's What You Should Know - MSN

Jan 18, 2025

Jan 18, 2025

Retail Investors Bet On Anavex Lifesciences Stock To Outperform Novavax, Rigel Pharma In Q1 On Alzheimer’s Drug Buzz - MSN

Jan 18, 2025

Jan 17, 2025

Rigel (RIGL) Upgraded to Buy: Here's Why - MSN

Jan 17, 2025

Jan 17, 2025

Equities Analysts Set Expectations for RIGL Q4 Earnings - MarketBeat

Jan 17, 2025

Jan 16, 2025

Rigel Pharmaceuticals Seeks for Acquisitions -January 16, 2025 at 11:15 am EST - Marketscreener.com

Jan 16, 2025

Jan 16, 2025

Cantor Fitzgerald Has Positive View of RIGL FY2024 Earnings - MarketBeat

Jan 16, 2025

Jan 14, 2025

Rigel Pharmaceuticals' (RIGL) "Buy" Rating Reaffirmed at HC Wainwright - MarketBeat

Jan 14, 2025

Jan 13, 2025

Rigel forecasts revenue growth in 2025, reports Q4 sales - Investing.com India

Jan 13, 2025

Jan 13, 2025

RIGLRigel Pharmaceuticals Inc. (New) Latest Stock News & Market Updates - StockTitan

Jan 13, 2025

Jan 13, 2025

Rigel Pharmaceuticals sets 2025 sales outlook above estimates - MSN

Jan 13, 2025

Jan 13, 2025

Rigel forecasts revenue growth in 2025, reports Q4 sales By Investing.com - Investing.com South Africa

Jan 13, 2025

Jan 13, 2025

Rigel Provides Business Update and 2025 Outlook - PR Newswire

Jan 13, 2025

Jan 13, 2025

Rigel Pharma Revenue Soars as TAVALISSE Hits $100M Sales Milestone, Sets Ambitious 2025 Targets - StockTitan

Jan 13, 2025

Jan 09, 2025

(RIGL) Technical Data - Stock Traders Daily

Jan 09, 2025

Jan 09, 2025

Rigel announces R289 granted Orphan Drug designation by FDA for MDS - TipRanks

Jan 09, 2025

Jan 09, 2025

Rigel Pharmaceuticals Gets FDA Orphan-Drug Designation for R289 - MarketWatch

Jan 09, 2025

Jan 09, 2025

Rigel Announces R289 Granted Orphan Drug Designation by the FDA for MDS - PR Newswire

Jan 09, 2025

Jan 09, 2025

Rigel's MDS Drug R289 Receives FDA Orphan Drug Status, Boosting Market Exclusivity Potential - StockTitan

Jan 09, 2025

Jan 08, 2025

Rigel to Present at the 43rd Annual J.P. Morgan Healthcare Confe - GuruFocus.com

Jan 08, 2025

Jan 08, 2025

Rigel to Present at the 43rd Annual J.P. Morgan Healthcare Conference - PR Newswire

Jan 08, 2025

Jan 08, 2025

Jane Street Group LLC Lowers Holdings in Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) - MarketBeat

Jan 08, 2025

Jan 03, 2025

Rigel Pharmaceuticals, Inc. Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4) - The Malaysian Reserve

Jan 03, 2025

Jan 03, 2025

Brokerages Set Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) PT at $36.20 - MarketBeat

Jan 03, 2025

Jan 01, 2025

Rigel Pharma expects to complete workforce reduction by Dec 15 - Reuters

Jan 01, 2025

Dec 30, 2024

Rigel Pharmaceuticals: Realizing The Promise Of Its Acquired Pipeline Agents (NASDAQ:RIGL) - Seeking Alpha

Dec 30, 2024

Dec 30, 2024

Rigel enrols first participant in Phase Ib/II AML treatment regimen trial - MSN

Dec 30, 2024

Dec 26, 2024

Rigel Pharmaceuticals (NASDAQ:RIGL) Shares Pass Above 200 Day Moving AverageShould You Sell? - MarketBeat

Dec 26, 2024

Dec 20, 2024

Lacklustre Performance Is Driving Rigel Pharmaceuticals, Inc.'s (NASDAQ:RIGL) 28% Price Drop - Simply Wall St

Dec 20, 2024

Dec 19, 2024

Rigel to Present at the Jefferies London Healthcare Conference - The Eastern Progress Online

Dec 19, 2024

Dec 19, 2024

(RIGL) Trading Signals - Stock Traders Daily

Dec 19, 2024

Dec 13, 2024

Rigel Pharmaceuticals' SWOT analysis: stock poised for growth amid challenges - Investing.com Australia

Dec 13, 2024

Dec 12, 2024

Recent 26% pullback isn't enough to hurt long-term Rigel Pharmaceuticals (NASDAQ:RIGL) shareholders, they're still up 50% over 1 year - Yahoo Finance

Dec 12, 2024

Dec 12, 2024

Thérapeutique Knight annonce l’approbation réglementaire de TAVALISSE® au Mexique - GlobeNewswire Inc.

Dec 12, 2024

Dec 12, 2024

Rigel Pharmaceuticals (NASDAQ:RIGL) shareholders are still up 50% over 1 year despite pulling back 26% in the past week - Simply Wall St

Dec 12, 2024

Dec 11, 2024

Immune Thrombocytopenia Purpura Market to Expand Significantly by 2034, States DelveInsight Report | Biotest, Argenx, Sanofi, Principia Biopharma, Rigel Pharma, Principia Biopharma, GlaxoSmithKline - The Globe and Mail

Dec 11, 2024

Dec 10, 2024

Rigel to Present at the 2024 Cantor Global Healthcare Conference - The Eastern Progress Online

Dec 10, 2024

Dec 10, 2024

Rigel Highlights Initial Data from Ongoing Phase 1b Study Evaluating R289 in LR-MDS at the 66th ASH Annual Meeting and Exposition - The Malaysian Reserve

Dec 10, 2024

Dec 10, 2024

Rigel Pharmaceuticals (NASDAQ:RIGL) Given "Buy" Rating at HC Wainwright - MarketBeat

Dec 10, 2024

Dec 09, 2024

Rigel Pharmaceuticals announces initial data from Phase 1b study of R289 - TipRanks

Dec 09, 2024

Dec 09, 2024

Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Receives Consensus Rating of "Hold" from Analysts - MarketBeat

Dec 09, 2024